-
EVAX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
Evaxion Biotech A/S (EVAX)
Company Profile
Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 9 |
Opened positions | 2 |
Closed positions | 2 |
Increased positions | 1 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 681.50 mm |
Total shares | 806.48 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
MRK Merck & Co. | 542.28 k | $458.44 mm |
Armistice Capital | 150.46 k | $127.20 mm |
Invst | 50.40 k | $42.61 mm |
Catalina Capital | 34.86 k | $29.47 mm |
Millennium Management | 22.54 k | $18.77 mm |
Beacon Capital Management | 4.86 k | $4.11 mm |
JPM JPMorgan Chase & Co. | 780.00 | $650.00 k |
Rhumbline Advisers | 290.00 | $240.00 k |
SSB SouthState | 4.00 | $3.00 k |
Proequities | 0.00 | $0.00 |